Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
US6172095A · kind A · utility
4Cited by
5References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 9, 1999 |
| Grant date | Jan 9, 2001 |
| Priority date | — |
| Expiry date | Aug 9, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention involves compounds having the structure (I) as described in the claims, and enantiomers,optical isomers, stereoisomers, diastereomers, tautomers, addition salts, biohydrolyzable amides and esters thereof, as well as pharmaceutical compositions comprising such noved compounds. The invention also relates to the use of such compounds for preventing or treating disorders modulated by alpha-2 adrenoceptors. ##STR1##
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.